Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A21152 | 25514910 | Rev Recent Clin Trials | Common features of the metabolic syndrome and nonalcoholic fatty liver disease. | 2014 | Details |
| A21155 | 25514907 | Rev Recent Clin Trials | Insulin resistance, non-alcoholic fatty liver disease and hepatitis C virus infection. | 2014 | Details |
| A21157 | 25514415 | Int J Mol Sci | Irisin, a link among fatty liver disease, physical inactivity and insulin resistance. | 2014 | Details |
| A21161 | 25512797 | World J Diabetes | Nonalcoholic steatohepatitis and insulin resistance in children. | 2014 | Details |
| A21165 | 25509904 | Ter Arkh | [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease]. | 2014 | Details |
| A21166 | 25509888 | Ter Arkh | [Adiponectin and parameters of glucose and lipid metabolism at different clinical and morphological stages of non-alcoholic fatty liver disease in patients with abdominal obesity]. | 2014 | Details |
| A21171 | 25502558 | PLoS One | A model of metabolic syndrome and related diseases with intestinal endotoxemia in rats fed a high fat and high sucrose diet. | 2014 | Details |
| A21185 | 25493023 | World J Gastroenterol | Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease. | 2014 | Details |
| A21187 | 25492998 | World J Gastroenterol | Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A21188 | 25492997 | World J Gastroenterol | Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet. | 2014 | Details |
| A21191 | 25491010 | Eur J Intern Med | The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A21196 | 25485911 | Nat Med | Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. | 2014 | Details |
| A21197 | 25484079 | Autophagy | Calcium channel blockers as potential therapeutics for obesity-associated autophagy defects and fatty liver pathologies. | 2014 | Details |
| A21205 | 25479248 | Nutrients | The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease. | 2014 | Details |
| A21212 | 25477509 | J Biol Chem | Adipocyte-specific disruption of fat-specific protein 27 causes hepatosteatosis and insulin resistance in high-fat diet-fed mice. | 2014 | Details |
| A21214 | 25476828 | Life Sci | Chronic intermittent hypobaric hypoxia ameliorates endoplasmic reticulum stress mediated liver damage induced by fructose in rats. | 2014 | Details |
| A21217 | 25473159 | World J Gastroenterol | Gut microbiota and metabolic syndrome. | 2014 | Details |
| A21219 | 25470627 | Diabetes Metab Syndr | The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children. | 2013 | Details |
| A21229 | 25469013 | World J Gastroenterol | Obesity, fatty liver disease and intestinal microbiota. | 2014 | Details |
| A21230 | 25468829 | Int J Obes (Lond) | Fetuin-A: a novel link between obesity and related complications. | 2014 | Details |
| A21231 | 25468788 | Med Hypotheses | Pentoxifylline in the management of metabolic syndrome and chronic hepatitis C. | 2014 | Details |
| A21243 | 25459558 | Clin Gastroenterol Hepatol | Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants. | 2014 | Details |
| A21245 | 25457209 | J Hepatol | Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2. | 2014 | Details |
| A21247 | 25456868 | Am J Cardiol | Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk. | 2014 | Details |
| A21250 | 25456097 | Metabolism | Leptin in nonalcoholic fatty liver disease: a narrative review. | 2014 | Details |
| A21255 | 25453513 | J Med Food | Green Tea Lowers Hepatic COX-2 and Prostaglandin E2 in Rats with Dietary Fat-Induced Nonalcoholic Steatohepatitis. | 2014 | Details |
| A21256 | 25452862 | BMJ Open Diabetes Res Care | Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease. | 2014 | Details |
| A21259 | 25450719 | J Hepatol | Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine. | 2014 | Details |
| A21262 | 25450583 | Arch Med Res | Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress. | 2014 | Details |
| A21269 | 25445398 | J Hepatol | TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess. | 2014 | Details |
| A21283 | 27356367 | Bull Acad Natl Med | [Metabolic syndrome, non alcoholic hepatic steatopathy and hepatocellular carcinoma: so dangerous liaisons]. | 2014 | Details |
| A21287 | 25433106 | Nutr Hosp | Vitamin D levels and bone turnover markers are not related to non-alcoholic fatty liver disease in severely obese patients. | 2014 | Details |
| A21288 | 25430922 | Pharm Biol | A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation. | 2014 | Details |
| A21290 | 25429984 | Hepatol Res | Serum alanine aminotransferase predicts the histological course of non-alcoholic steatohepatitis in Japanese patients. | 2014 | Details |
| A21293 | 25429318 | World J Hepatol | Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease. | 2014 | Details |
| A21295 | 25427907 | Adv Exp Med Biol | Understanding the tumor suppressor PTEN in chronic alcoholism and hepatocellular carcinoma. | 2015 | Details |
| A21300 | 25422863 | Biochem J | Steatosis inhibits liver cell store-operated Ca²⁺ entry and reduces ER Ca²⁺ through a protein kinase C-dependent mechanism. | 2015 | Details |
| A21304 | 25419656 | PLoS One | Longitudinal assessment of high blood pressure in children with nonalcoholic fatty liver disease. | 2014 | Details |
| A21308 | 25415231 | Horm Metab Res | Leptin improves fatty liver independently of insulin sensitization and appetite suppression in hepatocyte-specific Pten-deficient mice with insulin hypersensitivity. | 2014 | Details |
| A21310 | 25414939 | Postgrad Med | Diabetes mellitus as a novel risk factor for gastrointestinal malignancies. | 2014 | Details |
| A21313 | 25413107 | Liver Int | Effect of enforced physical inactivity induced by 60-day of bed rest on hepatic markers of NAFLD in healthy normal-weight women. | 2015 | Details |
| A21317 | 25411646 | J Clin Med | Reducing Liver Fat by Low Carbohydrate Caloric Restriction Targets Hepatic Glucose Production in Non-Diabetic Obese Adults with Non-Alcoholic Fatty Liver Disease. | 2014 | Details |
| A21323 | 25405502 | J Clin Endocrinol Metab | Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes. | 2014 | Details |
| A21328 | 25402369 | Hormones (Athens) | Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis. | 2014 | Details |
| A21329 | 25401691 | Nat Med | The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. | 2014 | Details |
| A21332 | 25400437 | World J Gastroenterol | Liver transplantation and non-alcoholic fatty liver disease. | 2014 | Details |
| A21333 | 25400436 | World J Gastroenterol | Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease. | 2014 | Details |
| A21334 | 25399407 | Ital J Pediatr | Chemerin as a novel non-invasive serum marker of intrahepatic lipid content in obese children. | 2014 | Details |
| A21335 | 25399255 | BMC Genomics | A network biology workflow to study transcriptomics data of the diabetic liver. | 2014 | Details |
| A21340 | 25390016 | Horm Mol Biol Clin Investig | The pathophysiology of abdominal adipose tissue depots in health and disease. | 2014 | Details |
| A21344 | 25386164 | Front Endocrinol (Lausanne) | Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments. | 2014 | Details |
| A21346 | 25386071 | World J Gastroenterol | Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3. | 2014 | Details |
| A21347 | 25386056 | World J Gastroenterol | MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease. | 2014 | Details |
| A21352 | 25382334 | Chin Med J (Engl) | Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease. | 2014 | Details |
| A21357 | 25380394 | Eur J Gastroenterol Hepatol | A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomes. | 2015 | Details |
| A21359 | 25378958 | Hepat Med | Surgical treatment of nonalcoholic fatty liver disease in severely obese patients. | 2014 | Details |
| A21365 | 25371775 | Oxid Med Cell Longev | Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective. | 2014 | Details |
| A21370 | 25371150 | J Cell Biochem | The hepatic transcriptome of young suckling and aging intrauterine growth restricted male rats. | 2015 | Details |
| A21373 | 25367327 | Food Funct | Effects of Callistephus chinensis flower polyphones on improving metabolic disorders in high-fat diet-induced mice. | 2014 | Details |
| A21379 | 25359230 | J Nutrigenet Nutrigenomics | The single nucleotide polymorphism rs499765 is associated with fibroblast growth factor 21 and nonalcoholic fatty liver disease in a Chinese population with normal glucose tolerance. | 2014 | Details |
| A21380 | 25358448 | Endocrine | Plasma levels of SIRT1 associate with non-alcoholic fatty liver disease in obese patients. | 2014 | Details |
| A21382 | 29764046 | Per Med | Personalizing care for nonalcoholic fatty liver disease patients: what are the research priorities? | 2014 | Details |
| A21384 | 25356056 | World J Gastroenterol | Therapeutic effects of globular adiponectin in diabetic rats with nonalcoholic fatty liver disease. | 2014 | Details |
| A21385 | 25356042 | World J Gastroenterol | Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation. | 2014 | Details |
| A21386 | 25356033 | World J Gastroenterol | ADV36 adipogenic adenovirus in human liver disease. | 2014 | Details |
| A21395 | 25351290 | Liver Int | The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis. | 2014 | Details |
| A21399 | 25349437 | Proc Natl Acad Sci U S A | DLK1/PREF1 regulates nutrient metabolism and protects from steatosis. | 2014 | Details |
| A21409 | 25343462 | PLoS One | Association between serum irisin levels and non-alcoholic fatty liver disease in health screen examinees. | 2014 | Details |
| A21410 | 25341597 | Turk J Pediatr | Leptin-to-adiponectin ratio in obese adolescents with nonalcoholic fatty liver disease. | 2016 | Details |
| A21413 | 25339808 | World J Gastroenterol | Non-alcoholic fatty liver disease: what has changed in the treatment since the beginning? | 2014 | Details |
| A21416 | 25339805 | World J Gastroenterol | Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. | 2014 | Details |
| A21417 | 25336983 | J Inflamm Res | β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model. | 2014 | Details |
| A21418 | 25333896 | Mol Med Rep | Polydatin supplementation ameliorates diet-induced development of insulin resistance and hepatic steatosis in rats. | 2014 | Details |
| A21422 | 25331487 | Ann Gastroenterol | The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study. | 2014 | Details |
| A21425 | 25328713 | Int J Hepatol | Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease. | 2014 | Details |
| A21431 | 25324136 | Horm Res Paediatr | Non-alcoholic fatty liver and metabolic syndrome in children: a vicious circle. | 2014 | Details |
| A21432 | 25320541 | World J Gastroenterol | Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population. | 2014 | Details |
| A21440 | 25317811 | Eur Rev Med Pharmacol Sci | Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH). | 2014 | Details |
| A21441 | 25316683 | JPEN J Parenter Enteral Nutr | Branched-Chain Amino Acid-Rich Supplements Containing Microelements Have Antioxidant Effects on Nonalcoholic Steatohepatitis in Mice. | 2014 | Details |
| A21443 | 25313081 | Proc Natl Acad Sci U S A | Obesity accelerates epigenetic aging of human liver. | 2014 | Details |
| A21445 | 25312648 | Mol Cell Biol | Hepatic mitogen-activated protein kinase phosphatase 1 selectively regulates glucose metabolism and energy homeostasis. | 2014 | Details |
| A21448 | 25311381 | Clin Gastroenterol Hepatol | Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile. | 2014 | Details |
| A21451 | 25310357 | Mol Med Rep | Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice. | 2014 | Details |
| A21452 | 25310017 | Food Funct | Total saponins from Rosa laevigata Michx fruit attenuates hepatic steatosis induced by high-fat diet in rats. | 2014 | Details |
| A21455 | 25309067 | World J Gastroenterol | Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. | 2014 | Details |
| A21457 | 25307311 | Mini Rev Med Chem | Long chain omega-3 polyunsaturated fatty acids in pediatric metabolic syndrome. | 2014 | Details |
| A21460 | 25305772 | Arch Iran Med | Systematic review: endocrine abnormalities in patients with liver cirrhosis. | 2014 | Details |
| A21462 | 25303488 | J Clin Endocrinol Metab | High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. | 2014 | Details |
| A21468 | 25298375 | Eur J Endocrinol | External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. | 2014 | Details |
| A21470 | 25297827 | Hepatol Res | Human placental extract treatment for non-alcoholic steatohepatitis non-responsive to lifestyle intervention: A pilot study. | 2014 | Details |
| A21472 | 25296088 | Arq Gastroenterol | Ginseng, green tea or fibrate: valid options for nonalcoholic steatohepatitis prevention? | 2015 | Details |
| A21473 | 25296075 | Arq Gastroenterol | Age and gender may influence the results of Roux-en-Y gastric bypass? Metabolic syndrome parameters. | 2015 | Details |
| A21479 | 25292174 | Obesity (Silver Spring) | Obesity depresses the anti-inflammatory HSP70 pathway, contributing to NAFLD progression. | 2014 | Details |
| A21483 | 25289058 | Exp Ther Med | Heparin modulation on hepatic nitric oxide synthase in experimental steatohepatitis. | 2014 | Details |
| A21487 | 25282656 | J Nutr Biochem | Protein carbonylation associated to high-fat, high-sucrose diet and its metabolic effects. | 2014 | Details |
| A21489 | 25281863 | J Hepatol | Acid sphingomyelinase-ceramide system in steatohepatitis: a novel target regulating multiple pathways. | 2014 | Details |
| A21492 | 25281760 | J Lipid Res | Deletion of ELOVL6 blocks the synthesis of oleic acid but does not prevent the development of fatty liver or insulin resistance. | 2014 | Details |
| A21493 | 25281430 | Diabetes | WISP1 is a novel adipokine linked to inflammation in obesity. | 2014 | Details |
| A21494 | 25278691 | World J Gastroenterol | Non-alcoholic fatty liver disease: what the clinician needs to know. | 2014 | Details |
| A21495 | 25278690 | World J Gastroenterol | Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors. | 2014 | Details |